Changes in glycaemic control and risk of coronary artery disease in type 1 diabetes mellitus: Findings from the Pittsburgh Epidemiology of Diabetes Complications Study (EDC)

Diabetologia

Volumn 50, Issue 11, 2007, Pages 2280-2288

  Prince, C T ^a   Becker, D J ^b   Costacou, T ^a   Miller, R G ^a   Orchard, T J ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Childhood onset diabetes; Coronary heart disease; Epidemiology; Glycaemic control; HbA1c; Macrovascular complications; Type 1 diabetes

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; FEMALE; GLYCEMIC CONTROL; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REVASCULARIZATION;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CORONARY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PENNSYLVANIA; RISK FACTORS;

EID: 34848815430     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0797-7     Document Type: Article

References (32)

1. Nathan DM (1993) Long-term complications of diabetes mellitus. N Engl J Med 328:1676-1685
2. Deckert T, Poulsen JE, Larsen M (1979) Prognosis of diabetics with diabetes onset before the age of thirty-one. II. Factors influencing the prognosis. Diabetologia 14:371-377
3. Laing SP, Swerdlow AJ, Slater SD et al (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760-765
4. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL (1988) Glycosylated haemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 260:2864-2871
5. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH (1995) Glycosylated haemoglobin and the risk of microalbuminuria in patients with insulin-dependent diabetes mellitus. N Engl J Med 332:1251-1255
6. Lehto S, Ronnemaa T, Pyorala K, Laakso M (1999) Poor glycaemic control predicts coronary heart disease events in patients with type 1 diabetes without nephropathy. Arterioscler Thromb Vasc Biol 19:1014-1019
7. Klein BE, Klein R, McBride PE et al (2004) Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 164:1917-1924
8. Soedamah-Muthu SS, Chaturvedi N, Toeller M et al (2004) EURODIAB Prospective Complications Study Group: risk factors for coronary heart disease in type 1 diabetic patients in Europe: the EURODIAB Prospective Complications Study. Diabetes Care 27:530-537
9. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH (1996) Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. Br Med J 313:779-784
10. Orchard TJ, Olson JC, Erbey JR et al (2003) Insulin resistance-related factors, but not glycaemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 26:1374-1379
11. Forrest KY, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ (2000) Are predictors of coronary heart disease and lower extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 148:159-169
12. Selvin E, Marinopoulos S, Berkenblit G, Rami T, Brancati FL, Powe NR (2004) Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med 141:421-431
13. Stettler C, Allemann S, Juni P et al (2006) glycaemic control and macrovascular disease in types 1 and 2 diabetes mellitus: meta-analysis of randomized trials. Am Heart J 152:27-38
14. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group (2005) Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353:2643-2653
15. UK Prospective Diabetes Study (UKPDS) Group (1998) Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352:837-853 (Erratum, Lancet 354:602, 1999)
16. Orchard TJ, Dorman JS, Maser RE et al (1990) Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications Study II. Diabetes 39:1116-1124
17. Orchard TJ, Dorman JS, Maser RE et al (1990) Factors associated with avoidance of severe complications after 25 yr of IDDM. Pittsburgh Epidemiology of Diabetes Complications Study I. Diabetes Care 13:741-747
18. Borhani NO, Kass EH, Langford HG, Payne GH, Remington RD, Stamier J (1976) The hypertension detection and follow-up program. Prev Med 5:207-215
19. Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ (2000) Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes 49:626-632
20. Warnick GR, Albers JJ (1978) Heparin-Mn2+ quantitation of high-density-lipoprotein cholesterol: an ultrafiltration procedure for lipemic samples. Clin Chem 24:900-904
21. National Institutes of Health, Department of Health (1975) Lipid research clinics program. US Government Printing Office, Washington, DC, pp 75-628
22. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475
23. Bucolo G, David H (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19:476-482
24. Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
25. Ellis D, Buffone GJ (1977) A new approach to the evaluation of proteinuric states. Clin Chem 23:666-670
26. Prineas RJ, Crow RS, Blackburn H (1982) The Minnesota code manual of electrocardiographic findings: standards and procedures for measurement and classification. John Wright, Littleton, MA
27. Williams KV, Erbey JR, Becker D, Orchard TJ (1999) Improved glycaemic control reduces the impact of weight gain on cardiovascular risk factors in type 1 diabetes. The Epidemiology of Diabetes Complications Study. Diabetes Care 22:1084-1091
28. Emerson PA, Marks P (1977) Preventing thromboembolism after myocardial infarction: effect of low-dose heparin or smoking. Br Med J 1:18-20
29. Badaracco MA, Vessey MP (1974) Recurrence of venous thromboembolic disease and use of oral contraceptives. Br Med J 1:215-217
30. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 351:1296-1305
31. Orchard TJ, Costacou T, Kretowski A, Nesto RW (2006) Coronary artery disease and type 1 diabetes. Diabetes Care 29:2528-2538
32. Orchard TJ, Forrest KY-Z, Ellis D, Becker DJ (1997) Cumulative glycaemic exposure and microvascular complications in insulin dependent diabetes mellitus. Arch Intern Med 157:1851-1856